Journal of Neuroscience, Vol 15, 7150-7157, Copyright © 1995 by Society for Neuroscience
Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study
AI Hersi, JW Richard, P Gaudreau and R Quirion
Department of Neurology/Neurosurgery, McGill University, Montreal, Quebec, Canada.
The modulation of in vivo hippocampal ACh release by dopaminergic D1 and D2
receptors was examined in this study. Additionally, in an attempt to
ascertain the location of these receptors in relation to hippocampal
cholinergic terminals, fimbriaectomy and quantitative autoradiography were
used. Following unilateral fimbriaectomy, whereby at least 50% of
hippocampal cholineacetyltransferase (ChAT) activity was lost, a
significant ipsilateral decrease in D1/3H SCH23390 binding was observed in
the molecular layer of the dentate gyrus while hippocampal D2/3H raclopride
binding was unaffected. The effects of prototypical D1 and D2 receptor
agonists and antagonists on hippocampal ACh release were examined next
using in vivo dialysis in freely moving rats. The D1 agonist SKF 38393 (10
microM to 100 microM) administered directly into the hippocampus via the
dialysis probe stimulated ACh release in a concentration dependent manner.
The effect of the agonist was blocked by the coadministration of the D1
receptor antagonist SCH 23390 (1 microM), which by itself failed to
modulate ACh release. In contrast, neither the D2 agonist quinpirole (1-10
microM) nor the D2 antagonist sulpiride (1-10 microM) had any direct effect
on hippocampal ACh release. Additionally, the infusion of these D1 and D2
drugs in the septal area failed to affect hippocampal ACh release. Taken
together, these results suggest that a proportion of hippocampal D1
receptors are located on cholinergic nerve terminals and that dopamine,
acting via D1 receptors, can locally stimulate hippocampal ACh release.
Previous Article | Next Article
